Hui-Kuo Shu
Medical Director · Emory University School of Medicine
Credentials: · · · · · ·
History
- 1999–2000
University of California
- 1989–1993
Research
International journal of radiation oncology · 2017 · 92 citations
Journal of Neuro-Oncology · 2017 · 79 citations
Journal of neurosurgery · 2019 · 55 citations
24 papers
18 papers · 1 as a fellow
18 papers · 1 as a fellow
18 papers
17 papers · 6 as a resident
- RP
16 papers · 16 as a resident
13 papers
- AV
11 papers
Grants
- 2017–2020
Spectroscopic MRI to Guide Radiation Dose Escalation for Glioblastoma Patients
National Cancer Institute · R01
PI · $739.1K · Emory University
- 2013–2018
Quantitative MRSI to Predict Early Response to SAHA Therapy in New GBM Management
National Cancer Institute · U01
PI · $3.2M · Emory University
- 2010–2012
Blockade of the SDF-1/CXCR4 Axis as a Novel Strategy for Mitigating Radiation-Ind
National Institute of Allergy and Infectious Diseases · RC1
Contact PI · $850.3K · Emory University
- 2009–2012
Inhibition of the SDF-1/CXCR4 Axis as Preventive Therapy for Radiation-Induced Pu
National Heart, Lung, and Blood Institute · R21
Contact PI · $426.3K · Emory University
Clinical trials
- 2022–2026
Natural Progesterone for the Treatment of Recurrent Glioblastoma
Principal investigator · Terminated · Early phase 1
Emory University
- 2018–2021
Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases
Principal investigator · Completed
Emory University
- 2017–2024
Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma
Principal investigator · Completed · Phase 2
Emory University
- 2014–2024
MRSI to Predict Response to RT/TMZ ± Belinostat in GBM
Principal investigator · Unknown · Phase 2
Emory University